OTCMKTS:ABCZY Abcam (ABCZY) Stock Price, News & Analysis → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free ABCZY Stock Alerts $19.40 +0.52 (+2.75%) (As of 10/29/2020) Add Compare Share Share Today's Range$19.09▼$19.4050-Day Range$19.40▼$19.4052-Week Range$11.26▼$19.73Volume5,400 shsAverage Volume4,712 shsMarket Capitalization$3.98 billionP/E RatioN/ADividend Yield0.36%Price TargetN/A Stock AnalysisStock Analysis Get Abcam alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Abcam Stock (OTCMKTS:ABCZY)Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Germany, the United Kingdom, and internationally. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc has partnership with Cancer Research UK for the development and commercialization of novel custom antibodies to support the acceleration of cancer research. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.Read More ABCZY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABCZY Stock News HeadlinesMarch 18, 2024 | msn.comLong-standing Danaher executive Markus Lusser becomes new president of AbcamMarch 18, 2024 | finance.yahoo.comAbcam appoints Markus Lusser as new PresidentMay 7, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. November 7, 2023 | msn.comDanaher deal for Abcam approved by 89 per cent of shareholdersNovember 6, 2023 | uk.news.yahoo.comAbcam shareholders approve $5.7 billion Danaher dealNovember 1, 2023 | thetimes.co.ukAbcam founder ends fight to block takeoverOctober 23, 2023 | finance.yahoo.comLeading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation’s Proposed Acquisition of AbcamOctober 21, 2023 | msn.comEfforts to stop takeover of biotech firm Abcam dealt a blowMay 7, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. October 19, 2023 | msn.comTop Abcam Investor HBK Voices Support for $5.7 Billion SaleOctober 17, 2023 | stockhouse.comLeading Proxy Advisor, ISS, Recommends Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of AbcamOctober 16, 2023 | proactiveinvestors.comExlusive: Why Abcam founder believes Danaher's acquisition offer falls shortOctober 16, 2023 | msn.comHBK Capital Becomes Biggest Abcam Investor, Set to Support SaleOctober 14, 2023 | msn.comAbcam founder's concern over exodus of British life science companiesOctober 14, 2023 | msn.comAbcam founder speaks out against growing exodus of British life science companiesOctober 12, 2023 | finance.yahoo.comIndependent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to DanaherOctober 5, 2023 | msn.comAbcam received multiple bids in sales process, contacted over 30 partiesOctober 5, 2023 | ft.comLife sciences group Abcam rejects founder’s accusations over $5.7bn deal with DanaherOctober 4, 2023 | msn.comAbcam challenger hits out as process to set EGM date goes onSeptember 28, 2023 | msn.comAbcam founder slams £4.5bn sale to US conglomerate DanaherSeptember 28, 2023 | ca.news.yahoo.comUK Life Sciences Firm Abcam’s Founder Fights $5.7 Billion BidSeptember 15, 2023 | msn.comUPDATE 3-Abcam founder seeks to block $5.7 billion Danaher dealSeptember 15, 2023 | msn.comSignal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founderSeptember 14, 2023 | finance.yahoo.comAbcam plc Statement on Dr. Jonathan Milner’s AnnouncementSeptember 14, 2023 | thetimes.co.ukAbcam founder Jonathan Milner renews clear-out bidSeptember 14, 2023 | investing.comAbcam plc founder to vote against proposed $5.7B Danaher acquisition, believes offer undervalues the companySeptember 14, 2023 | finance.yahoo.comDr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace BoardSee More Headlines Receive ABCZY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Industrial Inorganic Chemicals Sub-IndustryN/A Current SymbolOTCMKTS:ABCZY Previous SymbolNASDAQ:ABCZY CUSIPN/A CIKN/A Webwww.abcam.com Phone44 1223 696 000FaxN/AEmployees1,492Year Founded1998Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$336.37 million Price / Sales11.83 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares205,080,000Free FloatN/AMarket Cap$3.98 billion OptionableNot Optionable Beta1.29 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Alan Thomas Hirzel BS (Age 52)MS, MBA, CEO & Exec. Director Mr. Michael Shaun Baldock (Age 54)CFO & Director Dr. Jonathan Simon Milner (Age 55)Co-Founder & Non-Exec. Deputy Chairman Mr. Mark DermodyInterim CIOJames StaveleyVP of Investor RelationsKey CompetitorsImmunovantNASDAQ:IMVTGN Store Nord A/SOTCMKTS:GNNDYAblynxOTCMKTS:ABLYFAlkermesNASDAQ:ALKSAmbu A/SOTCMKTS:AMBBYView All Competitors ABCZY Stock Analysis - Frequently Asked Questions How have ABCZY shares performed in 2024? Abcam's stock was trading at $19.40 on January 1st, 2024. Since then, ABCZY stock has increased by 0.0% and is now trading at $19.40. View the best growth stocks for 2024 here. Is Abcam a good dividend stock? Abcam (OTCMKTS:ABCZY) pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.36%. Read our dividend analysis for ABCZY. How do I buy shares of Abcam? Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Abcam have any subsidiaries? The following companies are subsidiares of Abcam: Abcam (US) Ltd., Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., and Epitomics Inc.Read More This page (OTCMKTS:ABCZY) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe asset beating inflation by 4xColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
